Views & Analysis | Perspectives on pharma industry issues

Skip to main content

Saturday 25 April 2026

BlueSky linkedin youtube

header links

Get Newsletters
Media Kit

Pharmaphorum menu first category

News
Views & Analysis
Deep Dive
Webinars
Podcasts
Videos
Spotlight on
Events

close

SECTION

News
Views & Analysis
Deep Dive
Webinars
Podcasts
Videos
White Papers
Events

Channels

Channels

Sales & Marketing
R&D
Digital
Market Access
Oncology
Patients
Spotlight On

Channels

Sales & Marketing
R&D
Digital
Market Access
Oncology
Patients
Spotlight On

SUB NAVIGATION

Live Coverage
Partner Content
About us
Work for us
Contribute
Contact us
Advertise

Newsletters and Deep Dive digital magazine

youtube linkedin BlueSky

R&D

female technician in the lab

Women in STEM: Balancing the field from the beginning

pharmaphorum spoke with three female experts from Thermo Fisher Scientific about women in STEM today and tomorrow.

R&D

Map with medicines and pipette superimposed for global clinical trials concept

The devil’s in the details: Navigating complexity & nuance i...

Clinical trial expansion comes with complexity and increased risk, as each country has distinct regulatory requirements and contractual expectations.

R&D

neuron under microscope

Innovative direct delivery strategies to unlock oligonucleot...

Oligo therapies are emerging as promising therapeutics with the potential to address previously untreatable conditions.

Market Access

weight loss injections and measuring tape

Fighting fake GLP-1s to protect patients & preserve trust

Counterfeit drug promotion is a patient safety, brand equity, and public trust issue.

Digital

artificial intelligence chip with connected lines

Sponsored

Remove the friction to unlock the true potential of AI: Prec...

Frictionless AI is the foundation for Precision Intelligence: insight that is not simply faster or broader, but more decision-relevant.

Market Access

King chess piece

Illumina-Grail saga ends with divestment

In a case that had been closely watched across multiple industries, Illumina chose to divest Grail in the light of legal action from the European Commission and the US Federal Trade Commiss

Digital

pharmaphorum podcast episode 109

Key themes from JP Morgan

pharmaphorum editor-in-chief Jonah Comstock is back from San Francisco, where he attended the annual JP Morgan Healthcare Conference.

Patients

osteoporosis

Sponsored

How post-fracture care programmes such as fracture liaison s...

As society globally faces a growing elderly population, age-related conditions such as osteoporosis are coming to the forefront as critical issues. More emphasis needs to be placed on

Load more results

Sales & Marketing

Sales & Marketing

user scolling on smart phone

Sponsored

Solution Spotlight: Own The Moments That Matter Most

Medscape Contextual Moments is a suite of integrated opportunities that deliver messaging alongside independent Medscape trusted editorial content.

Sales & Marketing

Man listening to audio

Sponsored

Pushing through barriers to commercial launch success, with ...

In this sponsored pharmaphorum podcast, Amanjeet Singh Saluja, a Principal at Axtria, discusses the current state of affairs in launch success.

Digital

Digital

artificial intelligence chip with connected lines

Sponsored

Remove the friction to unlock the true potential of AI: Prec...

Frictionless AI is the foundation for Precision Intelligence: insight that is not simply faster or broader, but more decision-relevant.

Digital

Hallucination of an AI concept

Controlling AI hallucinations: Building evidence-based trust...

When it comes to GenAI, industry must demand evidence-grounded systems that prioritise verifiable clinical data and rigorous human oversight.

Market Access

Market Access

weight loss injections and measuring tape

Fighting fake GLP-1s to protect patients & preserve trust

Counterfeit drug promotion is a patient safety, brand equity, and public trust issue.

Market Access

Biotech capital concept

Capital discipline in biotech: Building enduring companies w...

Capital depends on the strength of the science, the quality of execution, and the ability to deliver on milestones as planned.

Editor's Picks

FDA clears first genetic hearing loss gene therapy

Trump signs order to hasten psychedelic medicine access

UK Knowledge Quarter welcomes Boehringer Ingelheim AI accelerator

UK Biobank patient data placed on sale in China

Medicare obesity drug pilot extended after insurer pushback

Newsletters and Deep Dive
digital magazine

Get Newsletters

Get in-depth news, opinions, and features on pharma and healthcare sent straight to your inbox

Oncology

Oncology

Precision medicine, DNA on target

From promise to practice: What must happen next for genetic ...

The systems needed to deliver GBT testing consistently across the NHS are still evolving to keep pace with these scientific advances.

Oncology

Interview at LSX 2026 with Roi Raz

LSX2026: Addressing adult eye cancer, with Roi Raz

Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.

Oncology

Oncologists assessing a brain scan

From preclinical toxicology to clinical safety: The path for...

Successfully navigating the process for drugs with a higher risk-benefit ratio requires a tailored non-clinical programme design.

Patients

Patients

pharmaphorum podcast Episode 256, Dean Erhardt, D2 Solutions

Providing patient access to new therapies, with Dean Erhardt

Dean Erhardt, founder of D2 Solutions, discusses patient access today versus the state of patient access tomorrow.

Patients

Pharmacist with patient and prescription

From access to advocacy: Turning patients into brand champio...

Done right, DTP is not just filling scripts. It is building loyalty that turns satisfied patients into lifelong advocates.

Patients

Anatomical graphic concept of a liver in 3D

Rewriting the MASLD playbook

Effective care now requires identifying metabolic risks early and addressing the broader factors driving liver damage.

R&D

R&D

female technician in the lab

Women in STEM: Balancing the field from the beginning

pharmaphorum spoke with three female experts from Thermo Fisher Scientific about women in STEM today and tomorrow.

R&D

Map with medicines and pipette superimposed for global clinical trials concept

The devil’s in the details: Navigating complexity & nuance i...

Clinical trial expansion comes with complexity and increased risk, as each country has distinct regulatory requirements and contractual expectations.

R&D

neuron under microscope

Innovative direct delivery strategies to unlock oligonucleot...

Oligo therapies are emerging as promising therapeutics with the potential to address previously untreatable conditions.

Editor's Picks

FDA clears first genetic hearing loss gene therapy

Trump signs order to hasten psychedelic medicine access

UK Knowledge Quarter welcomes Boehringer Ingelheim AI accelerator

UK Biobank patient data placed on sale in China

Medicare obesity drug pilot extended after insurer pushback

News

FDA grants three priority vouchers to psychedelics

FDA grants three priority vouchers to psychedelics

The FDA dropped a surprise Friday announcement that three more National Priority Vouchers would be given to a trio of psychedelics companies.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Sales & Marketing

Using AI-driven synthetic personas to take your insights further

Sponsored

Using AI-driven synthetic personas to take your insights fur...

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.

Pharmaphorum Menu

Digital
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Market Access
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Oncology
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Patients
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
R&D
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Sales & Marketing
- News
- Views & Analysis
- Deep Dive
- Webinars
- Podcasts
- Video
- White Papers
- Event
Spotlight on

Sign up for email newsletters and Deep Dive

Get Newsletters

youtube linkedin BlueSky

About us Advertising Contact us

Contribute Cookie Policy Privacy Policy

Terms & Conditions Work for us

The rights of trademark owners are acknowledged. Website and content copyright © 2009-2026, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – an EVERSANA company

The rights of trademark owners are acknowledged. Website and content copyright © 2009-2026, pharmaphorum media limited or its licensors; all rights reserved. pharmaphorum – an EVERSANA company